Surgery and ablative therapy for hepatocellular carcinoma Conference Paper


Authors: Cha, C.; DeMatteo, R. P.; Blumgart, L. H.
Title: Surgery and ablative therapy for hepatocellular carcinoma
Conference Title: Yale University Workshop on Hepatocellular Carcinoma
Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, responsible for an estimated one million deaths annually. The incidence in the United States has steadily increased over the past two decades. Although HCC has historically had a dismal prognosis, it is now being detected earlier as a result of improved radiologic imaging and surveillance. This affords the opportunity to treat patients with curative intent, and may improve survival. Partial hepatectomy and transplantation each provide potentially curative therapy for selected patients with HCC. Transplantation is indicated when there is severe underlying liver dysfunction. Local ablative therapy, such as ethanol injection, hepatic artery embolization, and radiofrequency ablation, offer palliation for patients when surgery is not feasible. The rational application of the myriad of therapies to a patient with HCC is designed to maximize both quality of life and survival.
Keywords: cancer survival; hepatocellular carcinoma; cisplatin; artificial embolism; liver cell carcinoma; liver transplantation; antineoplastic agents; carcinoma, hepatocellular; liver neoplasms; liver dysfunction; united states; conference paper; combined modality therapy; follow up; cancer incidence; cancer palliative therapy; quality of life; alcohol; surgery; anti-infective agents, local; yttrium radioisotopes; partial hepatectomy; catheter ablation; cryosurgery; hepatic artery; ethanol; cryotherapy; chemoembolization, therapeutic; injections, intra-arterial; injections, intralesional; humans; prognosis; human; priority journal; ablative therapy
Journal Title Journal of Clinical Gastroenterology
Volume: 35
Issue: 5 Suppl.2
Conference Dates: 2002 Mar 15-16
Conference Location: New Haven, CT
ISBN: 0192-0790
Publisher: Lippincott Williams & Wilkins  
Date Published: 2002-11-01
Start Page: S130
End Page: S137
Language: English
DOI: 10.1097/00004836-200211002-00009
PUBMED: 12449982
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 14 November 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leslie H Blumgart
    352 Blumgart
  2. Ronald P DeMatteo
    637 DeMatteo
  3. Charles   Hyung-Ki Cha
    4 Cha